The highs — and lows — of JPM 2024 you should pay attention to
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference, join our newsletter list.
JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations. Before you put the whole business of the conference behind you, here’s a look at what you might have missed and what’s worth pondering on what should be a well-earned break from all this biotech business.
Read Original Article: The highs — and lows — of JPM 2024 you should pay attention to »
